Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season

Safety surveillance is required for each season’s influenza vaccines to rapidly detect and evaluate potential new safety concerns before the peak period of immunization. Here we report the results of an enhanced passive safety surveillance for a trivalent split-virion inactivated influenza vaccine (...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Sonja Gandhi-Banga, Anne-Laure Chabanon, Cecile Eymin, Timothy Caroe, Karina Butler, Annick Moureau
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-09-01
Subjects:	influenza vaccines vaccination safety safety surveillance seasonal influenza adverse reaction adverse event reactogenicity immunization
Online Access:	http://dx.doi.org/10.1080/21645515.2019.1581538